ORLANDO, FL, USA (UroToday.com) - The authors presented results from a large population-based multicenter study which individualized intensification of treatment based on tumor marker response in patients with metastatic nonseminomatous germ-cell tumors (NSGTS).
Your session will expire in 8 hours requiring you to log in each day to view content.